NEW YORK — Thousands of bottles of the antidepressant duloxetine, which is sold under the brand name Cymbalta, have been recalled due to the presence of a toxic chemical, according to a notice from ...
Add Yahoo as a preferred source to see more of our stories on Google. A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially ...
Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic pain. A recent Food and Drug Administration (FDA) recall of a commonly ...
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National Library of Medicine describes as a toxic chemical, according to a notice from ...
Earlier this week, the U.S. Food and Drug Administration announced a significant recall of over 7,100 bottles of duloxetine, a generic form of the popular antidepressant Cymbalta. The recall was ...
More than 233,000 bottles of an antidepressant have been recalled by public health officials due to a chemical containing the risk of cancer. The U.S. Food and Drug Administration classified capsules ...
Duloxetine is the first drug to gain FDA approval for the indication of diabetic peripheral neuropathic pain. However, randomized controlled clinical trials of duloxetine for this indication have not ...
Diabetes is often complicated by diabetic peripheral neuropathic pain (DPNP). Current medications for pain of this origin carry notable side effects or efficacy problems. Duloxetine is a dual ...
Review the side-effects of Duloxetine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Please provide your email address to receive an email when new articles are posted on . Patients with central sensitization who received duloxetine slept 1.4 more hours on average in the first week ...
Four randomized, placebo-controlled, clinical trials of duloxetine for major depression have been published. [44–47] The studies are reviewed separately below, and additional details are provided in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results